227 results on '"Vlachogiannakos, Jiannis"'
Search Results
2. Comparing 2D-shear wave to transient elastography for the evaluation of liver fibrosis in nonalcoholic fatty liver disease
3. Alteration of small intestinal occludin and ZO‐1 expession in liver cirrhosis
4. Isolated nonspecific terminal ileitis: prevalence, clinical evolution and correlation with metachronous diagnosis of Crohn's disease: a retrospective study and review of the literature.
5. Obesity, insulin resistance and hyperandrogenism are implicated in the progression of liver stiffness (LS) in women with PCOS
6. Prevalence of cirrhotic cardiomyopathy according to different diagnostic criteria: alterations in ultrasonographic parameters of both left and right ventricles before and after stress.
7. Prevalence of cirrhotic cardiomyopathy according to different diagnostic criteria. Alterations in ultrasonographic parameters of both left and right ventricles before and after stress
8. Endoscopic diagnosis and management of esophagogastric variceal hemorrhage: European Society of Gastrointestinal Endoscopy (ESGE) Guideline
9. The Lyon Consensus Criteria for GERD Diagnosis in a Greek Population: The Clinical Impact and Changes in GERD Diagnosis in a Real-World, Retrospective Study
10. Hepatitis B: Who and when to treat?
11. Efficacy and safety of interferon-based therapy in the treatment of adult thalassemic patients with chronic hepatitis C: a 12 years audit
12. Endoscopic diagnosis and management of esophagogastric variceal hemorrhage:European Society of Gastrointestinal Endoscopy (ESGE) Guideline
13. Recent Advances in Cirrhotic Cardiomyopathy
14. Diastolic cardiac dysfunction is a predictor of dismal prognosis in patients with liver cirrhosis
15. HBV: Do I treat my immunotolerant patients?
16. Efficacy of citalopram or amitriptyline versus no treatment in patients with functional chest pain.
17. Gastrointestinal and liver side effects of drugs in elderly patients
18. Optimal therapy of chronic hepatitis B: how do I treat HBeAg-positive patients?
19. Frequency and Severity of Cirrhotic Cardiomyopathy and Its Possible Relationship with Bacterial Endotoxemia
20. Bleeding Lesions Within Reach of Conventional Endoscopy in Capsule Endoscopy Examinations for Obscure Gastrointestinal Bleeding: Is Repeating Endoscopy Economically Feasible?
21. Timing of hepatocellular carcinoma (HCC) development and predictability of a modified PAGE-B risk score in caucasian chronic hepatitis B (CHB) patients treated with entecavir (ETV) or tenofovir (TDF): 233
22. HBeAg-negative chronic hepatitis B: why do I treat my patients with pegylated interferon-alfa?
23. Differences between fellows and fellowship program directors in their perception of the impact of the COVID-19 pandemic on gastroenterology training: results from a nationwide survey in Greece
24. Platelet activation and hypercoagulability in patients with early primary biliary cholangitis compared with healthy controls
25. Long-term administration of rifaximin improves the prognosis of patients with decompensated alcoholic cirrhosis
26. Is bacterial DNA a better marker than endotoxin of bacterial translocation in decompensated cirrhosis?
27. New epidemiology of hepatitis delta
28. Long-term prognosis of cirrhotics with an upper gastrointestinal bleeding episode: Does infection play a role?
29. Ultrasound-guided liver biopsy in real life: Comparison of same-day prebiopsy versus real-time ultrasound approach
30. Single-session, graded esophageal dilation without fluoroscopy in outpatients with lower esophageal (Schatzkiʼs) rings: A prospective, long-term follow-up study
31. A single alcohol ingestion does not affect serum hepatitis C virus RNA in patients with chronic hepatitis C
32. Long-Term Acid Suppressive Therapy May Prevent the Relapse of Lower Esophageal (Schatzkiʼs) Rings: A Prospective, Randomized, Placebo-Controlled Study
33. Gastric electrical activity in patients with cholelithiasis undergoing laparoscopic cholecystectomy: A prospective controlled study
34. Clinical Course of Lamivudine Monotherapy in Patients with Decompensated Cirrhosis due to HBeAg negative chronic HBV infection
35. Bacterial infection in cirrhosis impairs coagulation by a heparin effect: a prospective study
36. Differences between fellows and fellowship program directors in their perception of the impact of the COVID-19 pandemic on gastroenterology training: results from a nationwide survey in Greece.
37. The effect of minimal dietary changes with raisins in NAFLD patients with non-significant fibrosis: a randomized controlled intervention
38. Optimal therapy of chronic hepatitis B: how do I treat HBeAg-positive patients?
39. Diastolic cardiac dysfunction is a predictor of dismal prognosis in patients with liver cirrhosis
40. HBeAg-negative chronic hepatitis B: why do I treat my patients with pegylated interferon-alfa?
41. The effect of minimal dietary changes with raisins in NAFLD patients with non-significant fibrosis: a randomized controlled intervention
42. Efficacy and safety of interferon-based therapy in the treatment of adult thalassemic patients with chronic hepatitis C: a 12 years audit
43. Frequency and Severity of Cirrhotic Cardiomyopathy and Its Possible Relationship with Bacterial Endotoxemia
44. Gastrointestinal and liver side effects of drugs in elderly patients
45. Optimal therapy of chronic hepatitis B: how do I treat HBeAg-positive patients?
46. Recent Advances in Cirrhotic Cardiomyopathy
47. Antiviral therapy reduces portal pressure in patients with cirrhosis due to HBeAg-negative chronic hepatitis B and significant portal hypertension
48. Combined use of metallic endoclips and endoloops using a single-channel scope in closing iatrogenic perforations and fistulas
49. HBeAg-negative chronic hepatitis B: why do I treat my patients with pegylated interferon-alfa?
50. Refractory GERD
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.